Key Financials Snapshot

TTM · Consolidated · ₹ in Cr
Market Cap
₹127 Cr.
Stock P/E
25.2
P/B
—
Current Price
₹62
Book Value
₹ 0
Face Value
10
52W High
₹72
52W Low
₹ 34
Dividend Yield
1.61%

Archit Organosys Overview

Business

Archit Organosys Ltd. is an Indian chemical manufacturing company primarily engaged in the production of specialty chemicals. Its core business revolves around manufacturing various dyes and dye intermediates, specifically for the textile industry. The company also produces other organic chemicals used in different industrial applications. It operates on a business-to-business (B2B) model, supplying its products to other manufacturers who use them as raw materials or intermediate products in their own production processes. The company generates revenue through the sale of these manufactured chemical products.

Revenue Mix

Archit Organosys Ltd. operates primarily in the specialty chemicals segment, with a significant focus on dyes and dye intermediates. While specific granular breakdowns of revenue by exact product type (e.g., reactive dyes vs. acid dyes vs. direct dyes) are not typically disclosed publicly, the company's operations are largely concentrated within this broader category, serving the textile and related industries. It does not typically report distinct major business segments beyond its core chemical manufacturing activities.

Industry

The Indian chemicals industry is diverse and fragmented, comprising both large integrated players and numerous small to medium-sized specialty chemical manufacturers. Archit Organosys operates within the specialty chemicals sub-segment, specifically targeting the dyes and intermediates market. This market is competitive, with both domestic and international players. The company positions itself by focusing on specific product niches, potentially leveraging cost efficiencies and customer relationships within its chosen segments. Its size places it among the smaller to mid-sized players in the broader Indian specialty chemicals landscape.

MOAT

Archit Organosys Ltd.'s competitive advantages are likely derived from:

Customer Relationships & Niche Expertise: Over time, developing strong relationships with textile manufacturers and gaining expertise in specific dye chemistries can create some switching costs for customers.

Cost Efficiency: While not always explicit, efficient manufacturing processes, procurement strategies, and operational scale (even if smaller than large peers) for its specific product lines can provide a cost advantage.

Regulatory Compliance: Adherence to environmental and quality standards is crucial in the chemical industry, and a good track record in this area can be a differentiator.

However, the company operates in a generally competitive market, and its moat may not be as wide or durable as companies with proprietary technology or very large scale.

Growth Drivers

Key factors that can drive Archit Organosys Ltd.'s growth over the next 3-5 years include:

Growth in End-User Industries: Increased demand from the Indian textile industry, both for domestic consumption and exports, directly impacts the demand for dyes and intermediates.

Capacity Expansion: Any planned increases in manufacturing capacity for existing or new products could drive higher sales volumes.

Product Diversification: Expansion into new specialty chemicals or intermediates that cater to other growing industrial sectors (e.g., agrochemicals, pharmaceuticals, pigments) could open new revenue streams.

Export Opportunities: Tapping into global markets for specialty chemicals, particularly in regions where manufacturing costs are higher, could boost growth.

"China Plus One" Strategy: Global supply chain diversification away from China could lead to increased orders for Indian chemical manufacturers.

Risks

Key business risks for Archit Organosys Ltd. include:

Raw Material Price Volatility: Fluctuations in the prices of crude oil and other basic chemical raw materials can significantly impact production costs and profit margins.

Environmental Regulations: The chemical industry is subject to stringent and evolving environmental norms; compliance costs and potential penalties for non-adherence can be substantial.

Competition: Intense competition from both domestic and international players can lead to pricing pressure and reduced market share.

Industry Downturns: A slowdown in the textile industry or general economic recession can negatively impact demand for its products.

Foreign Exchange Fluctuations: If the company has significant imports of raw materials or exports of finished goods, currency rate volatility can affect profitability.

Technological Obsolescence: Changes in dyeing technologies or the development of alternative materials could reduce demand for existing products.

Management & Ownership

Archit Organosys Ltd. is a promoter-driven company, common in India's mid-cap space. The promoters typically hold a significant stake in the company, aligning their interests with the long-term growth. The management team generally consists of individuals with experience in the chemicals sector, often including members of the founding family alongside professional managers. Specific details on individual management quality would require deeper analysis of their past performance, corporate governance practices, and financial stewardship over time, but generally, promoter-led entities often prioritize stability and sustainable growth within their industry niche.

Outlook

Archit Organosys Ltd. operates in the growing Indian specialty chemicals sector, benefiting from the fundamental demand of its end-user industries like textiles. The company's focus on niche products and established customer relationships provides a stable operational base. Potential growth drivers include increasing demand from domestic and export markets, capacity enhancements, and potential diversification into related chemical areas. However, the company faces inherent risks such as raw material price volatility, stringent environmental regulations, and intense competition, which can impact profitability. While its position as a smaller player in a fragmented market might limit rapid scaling compared to larger integrated peers, a disciplined approach to cost management, quality, and targeted product development could enable sustainable growth within its specialized segments. The company's future performance will largely depend on its ability to navigate these industry-specific challenges while capitalizing on demand tailwinds.

Archit Organosys Share Price

Live · BSE · Inception: 1993
₹ | |
Volume
Price

Key Financials — Profit & Loss

₹ in Cr · Consolidated · annual

Archit Organosys Quarterly Results

#(Fig in Cr.) Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
Net Sales 39 26 30 28 22 47 31 26 25 31
Other Income 1 0 0 0 0 1 1 1 1 1
Total Income 40 27 31 29 23 48 32 27 25 32
Total Expenditure 36 22 23 23 19 44 28 24 24 31
Operating Profit 4 5 7 5 4 4 4 3 2 1
Interest 1 1 1 0 1 1 1 1 1 1
Depreciation 1 1 1 1 1 1 1 1 1 1
Exceptional Income / Expenses 0 0 0 0 2 0 0 0 0 3
Profit Before Tax 3 3 5 4 4 3 2 1 -1 2
Provision for Tax 1 1 1 1 1 1 1 0 -0 0
Profit After Tax 2 2 4 3 2 2 2 0 -0 2
Adjustments 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 2 2 4 3 2 2 2 0 -0 2
Adjusted Earnings Per Share 1 0.9 2 1.5 1.1 0.9 0.8 0.2 -0.2 0.9

Archit Organosys Profit & Loss

#(Fig in Cr.) Mar 2023 Mar 2024 TTM
Net Sales 128 113 113
Other Income 2 2 4
Total Income 130 116 116
Total Expenditure 109 106 107
Operating Profit 21 9 10
Interest 2 3 4
Depreciation 5 6 4
Exceptional Income / Expenses 2 3 3
Profit Before Tax 15 4 4
Provision for Tax 4 1 1
Profit After Tax 11 3 4
Adjustments 0 0 0
Profit After Adjustments 11 3 4
Adjusted Earnings Per Share 5.5 1.6 1.7

Archit Organosys Balance Sheet

#(Fig in Cr.) Mar 2023 Mar 2024
Shareholder's Funds 62 64
Minority's Interest 0 0
Borrowings 14 8
Other Non-Current Liabilities 2 2
Total Current Liabilities 46 35
Total Liabilities 124 109
Fixed Assets 50 60
Other Non-Current Assets 22 7
Total Current Assets 52 42
Total Assets 124 109

Archit Organosys Cash Flow

#(Fig in Cr.) Mar 2023 Mar 2024
Opening Cash & Cash Equivalents 5 5
Cash Flow from Operating Activities 17 10
Cash Flow from Investing Activities -11 -2
Cash Flow from Financing Activities -7 -9
Net Cash Inflow / Outflow -0 -1
Closing Cash & Cash Equivalent 5 4

Archit Organosys Ratios

# Mar 2023 Mar 2024
Earnings Per Share (Rs) 5.53 1.6
CEPS(Rs) 7.91 4.35
DPS(Rs) 0.5 0
Book NAV/Share(Rs) 30.1 31.26
Core EBITDA Margin(%) 14.78 5.96
EBIT Margin(%) 13.71 6.1
Pre Tax Margin(%) 12.02 3.82
PAT Margin (%) 8.88 2.89
Cash Profit Margin (%) 12.7 7.89
ROA(%) 16.46 2.81
ROE(%) 34.94 5.2
ROCE(%) 34.08 7.56
Receivable days 61.76 96.08
Inventory Days 7.34 11.01
Payable days 60.61 85.46
PER(x) 10.92 27.1
Price/Book(x) 2.01 1.38
Dividend Yield(%) 0.83 0
EV/Net Sales(x) 1.17 0.97
EV/Core EBITDA(x) 7.21 11.99
Net Sales Growth(%) 514.14 -11.42
EBIT Growth(%) 1310.14 -60.59
PAT Growth(%) 2908.55 -71.14
EPS Growth(%) 743.66 -71.14
Debt/Equity(x) 0.5 0.4
Current Ratio(x) 1.13 1.21
Quick Ratio(x) 1.05 1.11
Interest Cover(x) 8.11 2.68
Total Debt/Mcap(x) 0.25 0.29

Growth Rates

Compounded annual
# 1 Year 3 Year 5 Year 10 Year
Sales CAGR -12% — — —
Operating Profit CAGR -57% — — —
PAT CAGR -73% — — —
Share Price CAGR +34% +4% +7% +9%
ROE Average +5% +20% +20% +20%
ROCE Average +8% +21% +21% +21%

Archit Organosys Shareholding Pattern

Latest · Jun 2026
100% held
Promoters 65.88 %
FII 0 %
DII (MF + Insurance) 0 %
Public (retail) 34.12 %
# Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Promoter 63.2664.6564.6564.8465.365.3965.3965.8665.8865.88
FII 0000000000
DII 0000000000
Public 36.7435.3535.3535.1634.734.6134.6134.1434.1234.12
Others 0000000000
Total 100100100100100100100100100100

Archit Organosys Peer Comparison

Chemicals Edit Columns

Archit Organosys Quarterly Price

10-year quarterly close · BSE
Show Value Show %

News & Updates

See more…

Archit Organosys Pros & Cons

Pros

  • Company has a good return on equity (ROE) track record: 3 Years ROE 20%
  • Company has reduced debt.
  • Company is almost debt free.

Cons

  • Debtor days have increased from 60.61 to 85.46days.
Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

whatsapp